Reuters – Quintiles IPO Raises More Than Planned

Drug researcher Quintiles Transnational Holdings raised a more-than planned $947 million in its IPO, the latest listing from a private equity-backed company, writes Reuters. Strong investor demand for the deal helped Quintiles, which is backed by Bain Capital and TPG Capital, price 20 percent more shares than expected at the top end of the range and pushed up pricing a day early, writes Reuters.